MétaCan
Menu
Retour à la cohorte
Enregistrement W2177390620 · doi:10.1016/j.semcancer.2015.09.007

Designing a broad-spectrum integrative approach for cancer prevention and treatment

2015· review· en· W2177390620 sur OpenAlex

Pourquoi ce travail est dans la base

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

affAu moins un auteur déclare une institution canadienne dans l'instantané OpenAlex épinglé.
fundUn bailleur canadien est enregistré sur le travail.

Notice bibliographique

RevueSeminars in Cancer Biology · 2015
Typereview
Langueen
DomaineComputer Science
ThématiqueComputational Drug Discovery Methods
Établissements canadiensSunnybrook Health Science CentreUniversity of TorontoDalhousie UniversityHealth Sciences CentreMcGill UniversityUniversity of WindsorChild and Family Research Institute
Organismes subventionnairesNational Institute of Environmental Health SciencesNational Institute of Allergy and Infectious DiseasesNational Center for Research ResourcesNational Institute of General Medical SciencesNational Cancer InstituteNational Heart, Lung, and Blood InstituteMedical Research CouncilCanadian Institutes of Health ResearchNational Institutes of HealthJunta de Castilla y LeónUnited Arab Emirates UniversityMinisterio de Ciencia e InnovaciónVetenskapsrådetKarolinska InstitutetNational Institute of Neurological Disorders and StrokeIkerbasque, Basque Foundation for ScienceRegione CampaniaMinistry of Education, Culture, Sports, Science and TechnologyBundesministerium für Bildung und ForschungAssociazione Italiana per la Ricerca sul CancroCancer Society of New ZealandAmerican Cancer SocietyMinistry of Science, ICT and Future PlanningShireBayer HealthCareNational Center for Complementary and Alternative MedicineCalifornia Breast Cancer Research ProgramBreast Cancer CampaignNational Research FoundationNational Institute for Health and Care ResearchTerry Fox FoundationSky FoundationU.S. Department of DefenseCancer Research UKBarbara Ann Karmanos Cancer InstituteWest Virginia Higher Education Policy CommissionMinisterstvo Zdravotnictví Ceské RepublikyNational Institute on Minority Health and Health DisparitiesEuropean CommissionNational Institute of Arthritis and Musculoskeletal and Skin DiseasesUniversity of MiamiState Council of Higher Education for VirginiaScottish GovernmentCancer Prevention and Research Institute of TexasRural and Environment Science and Analytical Services DivisionAvon Foundation for WomenWellcome TrustNational Science FoundationCancer Research WalesNational Institute on AgingHuntsman Cancer FoundationPfizerBristol-Myers SquibbNational Center for Complementary and Integrative HealthAgentura Pro Zdravotnický Výzkum České RepublikyTerry Fox Research InstituteAmerican Diabetes AssociationDamon Runyon Cancer Research FoundationEuropean Regional Development FundV Foundation for Cancer ResearchElsa U. Pardee FoundationInstituto de Salud Carlos IIINational Research Foundation of KoreaPancreatic Cancer Action NetworkBreast Cancer Research FoundationUniverzita Karlova v PrazeNational Institute of Diabetes and Digestive and Kidney DiseasesGilead SciencesNational Institute on Alcohol Abuse and AlcoholismUniversity of New South WalesNatural Environment Research CouncilUniversity of GlasgowU.S. Department of Veterans AffairsGrantová Agentura České RepublikyUnited Soybean Board
Mots-clésBroad spectrumTumor microenvironmentCancerMechanism (biology)Personalized medicineComputational biologyMedicineBioinformaticsDiseaseCancer therapyPrecision medicineBiologyCancer researchInternal medicineChemistryPathology

Résumé

récupéré en direct d'OpenAlex

Targeted therapies and the consequent adoption of "personalized" oncology have achieved notable successes in some cancers; however, significant problems remain with this approach. Many targeted therapies are highly toxic, costs are extremely high, and most patients experience relapse after a few disease-free months. Relapses arise from genetic heterogeneity in tumors, which harbor therapy-resistant immortalized cells that have adopted alternate and compensatory pathways (i.e., pathways that are not reliant upon the same mechanisms as those which have been targeted). To address these limitations, an international task force of 180 scientists was assembled to explore the concept of a low-toxicity "broad-spectrum" therapeutic approach that could simultaneously target many key pathways and mechanisms. Using cancer hallmark phenotypes and the tumor microenvironment to account for the various aspects of relevant cancer biology, interdisciplinary teams reviewed each hallmark area and nominated a wide range of high-priority targets (74 in total) that could be modified to improve patient outcomes. For these targets, corresponding low-toxicity therapeutic approaches were then suggested, many of which were phytochemicals. Proposed actions on each target and all of the approaches were further reviewed for known effects on other hallmark areas and the tumor microenvironment. Potential contrary or procarcinogenic effects were found for 3.9% of the relationships between targets and hallmarks, and mixed evidence of complementary and contrary relationships was found for 7.1%. Approximately 67% of the relationships revealed potentially complementary effects, and the remainder had no known relationship. Among the approaches, 1.1% had contrary, 2.8% had mixed and 62.1% had complementary relationships. These results suggest that a broad-spectrum approach should be feasible from a safety standpoint. This novel approach has potential to be relatively inexpensive, it should help us address stages and types of cancer that lack conventional treatment, and it may reduce relapse risks. A proposed agenda for future research is offered.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesMéta-épidémiologie (sens strict)
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Autre devis · Signal consensuel: aucune
GenreSignal candidat: Synthèse · Signal consensuel: Synthèse
Score de désaccord entre enseignants0,995
Score d'incertitude au seuil1,000

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0010,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0010,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0010,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,124
Tête enseignante GPT0,452
Écart entre enseignants0,328 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle